PROSPECTS FOR IMMUNOTHERAPY OF VIRUS-ASSOCIATED TUMORS
Authors: I.V. Samoilenko, Ya.I. Zhulikov, L.V. Demidov
Virus-associated malignancies are still common problem worldwide and in Russia
as well. In context of new treatment modalities development such as inhibition of
negative immune regulations or engineering immune cells with artificial receptors
which are capable to recognize viral antigens looks very attractive for billions of
patients worldwide. We reviewed the problem at the end of 2018.